In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Cancer Clinical Trials - NCBP-6637-0-CORD-BLOOD
Protocol Summary
- Protocol No
- NCBP-6637-0-CORD-BLOOD
- Principal Investigator
- David Margolis
- Phase
- II
- Title
- A multicenter safety study of unlicensed, investigational
cryopreserved cord blood units (CBUs) manufactured by the National
Cord Blood Program (NCBP) and provided for unrelated
hematopoietic stem cell transplantation of pediatric and adult patients
- Associated Disease(s)
-
Bone Marrow Transplant and Cellular Therapy
- Description (Summary)
- The main purpose of this study is to examine the safety of administration of unlicensed, investigational cord blood products used for stem cell transplant. We are studying the incidence of serious adverse reactions and infusion related reactions after patients are transplanted using these cord blood products.
- Participating Institutions
- Childrens Hospital of Wisconsin
- ClinicalTrials.gov
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
"The steady improvement in survival for children with cancer is a direct result of their enrollment onto clinical trials; without which we would remain decades behind in terms of scientific advances in pediatric cancer." ~Michael J. Burke, MD